Cargando…
Sphingolipids in Type 1 Diabetes: Focus on Beta-Cells
Type 1 diabetes (T1DM) is a chronic autoimmune disease, with a strong genetic background, leading to a gradual loss of pancreatic beta-cells, which secrete insulin and control glucose homeostasis. Patients with T1DM require life-long substitution with insulin and are at high risk for development of...
Autor principal: | Gurgul-Convey, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465050/ https://www.ncbi.nlm.nih.gov/pubmed/32759843 http://dx.doi.org/10.3390/cells9081835 |
Ejemplares similares
-
To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids
por: Gurgul-Convey, Ewa
Publicado: (2022) -
Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity
por: Tang, Yadi, et al.
Publicado: (2021) -
Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions
por: Pinheiro-Machado, Erika, et al.
Publicado: (2020) -
MCPIP1 regulates the sensitivity of pancreatic beta-cells to cytokine toxicity
por: Tyka, Karolina, et al.
Publicado: (2019) -
Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
por: Ayub, Maria, et al.
Publicado: (2021)